Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular system products. The company was formerly known as Ilsung Pharmaceuticals Co., Ltd. and changed its name to Ilsung Is Co., Ltd. in April 2024. Ilsung Is Co., Ltd. was founded in 1954 and is headquartered in Seoul, South Korea.
Metrics to compare | 003120 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship003120PeersSector | |
---|---|---|---|---|
P/E Ratio | 11.3x | 5.6x | −0.5x | |
PEG Ratio | 0.05 | −0.02 | 0.00 | |
Price/Book | 0.5x | 0.8x | 2.6x | |
Price / LTM Sales | 2.5x | 0.8x | 3.3x | |
Upside (Analyst Target) | - | 32.1% | 40.3% | |
Fair Value Upside | Unlock | 16.7% | 5.1% | Unlock |